Morphisec Cyber Security Blog

In less than two weeks, experts and enthusiasts from around the world will converge upon the Mandalay Bay resort in Las Vegas for Black Hat USA, one of the biggest information security events of the year. Black Hat is all about about the latest threat research, the newest hacking techniques and the most innovative technology, and Morphisec is excited to be a part of it. 

Attending Black Hat 2018? We'd love to meet up. Connect with members of the Morphisec team either in a personal meeting or at one of our many Black Hat events.

We all wish we were smarter. And I believe that the vast majority of people, in some way, strive to GET smarter.

As someone who has been involved in the cybersecurity industry for years, and watched it evolve, I see countless companies in this market using the aspect of intelligence to position themselves as being smarter than others. But if you have to proclaim your intelligence, are you actually smart? Or even smarter than me? Or than the next company?

After less than two years in the market, Morphisec has deployed its Endpoint Threat Prevention platform to over one million endpoints worldwide, making it the fastest subscription-based B2B cybersecurity company to reach this milestone.

Morphisec Moving Target Defense verified as Citrix Ready to enhance protection with Citrix XenApp and XenDesktop

CISOs face an escalating battle on two fronts: externally from ever-more sophisticated attackers and internally in managing all the threat protection and additional security layers they put in to stop them. And they are losing. Despite added technology complexity and operational overhead, cyber criminals still manage to get past defenses.

According to a a new report from analyst firm ESG, 72% of organizations believe that security operations are more difficult today than they were two years ago yet 54% still suffered at least one security incident.

The recent Meltdown and Spectre CPU vulnerabilities took almost everyone by surprise.  Widespread panic was staved off only by the promise of a nearly-ready OS patching fix, which it turned out, excluded a large swath of systems and created its own set of problems. 

Users are still scrambling to patch systems with an extremely complex mixture of OS, firmware and application updates. Organizations are encountering slowdowns, blue screens and reboot problems in their rush to avoid security problems. The entire stack of Spectre and Meltdown fixes has not yet been properly tested and will take time to reach anything resembling stability. 

Last month I discussed cybersecurity effectiveness, particularly in regards to the growing threat of fileless attacks. But effectiveness is only one piece of the equation.

First and foremost businesses still need to go about their business. Unfortunately, it has long been the case that the more effective a cybersecurity tool is, the slower and more intrusive it is and the more effort it takes to manage it. The complexity and pain of managing – not buying, managing! – security tools often forces companies to reconcile themselves to unacceptable exposure, for example to security-related business disruption, for want of resources to manage cumbersome defensive technology.

Last week I had the pleasure of speaking at the Israeli Dealmakers Summit in Silicon Valley. With over a thousand of the world’s top corporations, investors and entrepreneurs, it’s known as the largest and most prestigious Israel-focused business event. While it was exciting to participate, the real privilege was to be able to help showcase the innovative ideas and technology coming out of Israel.

Imagine this. You are in charge of public health and must deal with an unrelenting epidemic. You have two options for protecting the population.

The first option is to monitor each person for symptoms of infection. You buy analytical technology and infrastructure, hire staff and build hospitals. You send forth specialists to monitor everyone. When they notice symptoms, more tests are performed. The symptoms are
subtle (fatigue, headache, stiffness), and healthy and sick people look a lot alike, so to be on the safe side you test far more people than are truly ill. Once you suspect infection, you quarantine the person and start a course of treatment. Sometimes the people are cured. Sometimes they are not. You can’t guarantee that you will find everyone who is infected. Or that everyone you treat is ill. The monitoring and mandatory quarantine intrude on civil liberties, disrupt lives and interfere with the economy. To compound matters, the disease mutates, so you have to continually design new screening tests and retrain the specialists.